2551 GnRH antagonist plus bicalutamide may be an effective therapy as initial combined androgen blockade for patients with high grade prostate cancer. (September 2015) - Uemura, M.; Nagahara, A.; Yamamoto, Y.; Takada, S.; Inagaki, Y.; Kinouchi, T.; Miyake, O.; Nakazawa, S.; Nishimura, K.; Arai, H.; Honda, M.; Okada, K.; et al.